Quent Capital’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1K Sell
376
-80
-18% -$3.44K ﹤0.01% 1045
2025
Q4
$20K Buy
456
+155
+51% +$6.41K ﹤0.01% 988
2025
Q3
$12.4K Buy
+301
New +$12.1K ﹤0.01% 972
2025
Q2
Sell
-78
Closed -$2.88K 602
2025
Q1
$2.88K Hold
78
﹤0.01% 1101
2024
Q4
$2.6K Hold
78
﹤0.01% 1135
2024
Q3
$2.02K Hold
78
﹤0.01% 1224
2024
Q2
$1.75K Buy
78
+13
+20% +$288 ﹤0.01% 1227
2024
Q1
$1.54K Hold
65
﹤0.01% 1258
2023
Q4
$1.56K Hold
65
﹤0.01% 1225
2023
Q3
$1.42K Buy
+65
New +$1.36K ﹤0.01% 1218
2022
Q4
Sell
-3,064
Closed -$48K 1337
2022
Q3
$48K Hold
3,064
0.01% 554
2022
Q2
$64K Buy
3,064
+3,000
+4,688% +$61.8K 0.01% 455
2022
Q1
$1K Buy
+64
New +$1.25K ﹤0.01% 1188

Other funds holding EXEL

Quent Capital's EXEL Position: Q1 2026 in Review

Quent Capital reduced its Exelixis (EXEL) stake by 18% in Q1 2026, selling an estimated $3.44K and leaving 376 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1045.

Quent Capital first reported a position in EXEL in Q1 2022 and has held it in 13 quarters since. The position peaked at $64K in Q2 2022. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Quent Capital held 376 shares of Exelixis worth $16.1K as of Q1 2026.
  • Quent Capital sold 80 Exelixis shares in Q1 2026, an estimated $3.44K.
  • Exelixis made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1045 holding.
  • Quent Capital first reported a position in Exelixis in Q1 2022 and has held it in 13 quarters since.
  • Quent Capital's Exelixis position peaked at $64K in Q2 2022.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.